CN102114122A - 一种治疗慢性前列腺炎的中药 - Google Patents
一种治疗慢性前列腺炎的中药 Download PDFInfo
- Publication number
- CN102114122A CN102114122A CN2010105992043A CN201010599204A CN102114122A CN 102114122 A CN102114122 A CN 102114122A CN 2010105992043 A CN2010105992043 A CN 2010105992043A CN 201010599204 A CN201010599204 A CN 201010599204A CN 102114122 A CN102114122 A CN 102114122A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- chronic prostatitis
- parts
- radix
- Prior art date
Links
- 239000003814 drugs Substances 0.000 title claims abstract description 24
- 201000007094 prostatitis Diseases 0.000 title claims abstract description 13
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 11
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 11
- 210000000582 Semen Anatomy 0.000 claims description 10
- 239000010231 banlangen Substances 0.000 claims description 10
- 241000222336 Ganoderma Species 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 14
- 210000004369 Blood Anatomy 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 8
- 201000010099 diseases Diseases 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 230000001737 promoting Effects 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 208000004880 Polyuria Diseases 0.000 abstract description 3
- 230000035619 diuresis Effects 0.000 abstract description 3
- 230000000857 drug effect Effects 0.000 abstract description 3
- 230000001939 inductive effects Effects 0.000 abstract description 3
- 230000025627 positive regulation of urine volume Effects 0.000 abstract description 3
- 230000002485 urinary Effects 0.000 abstract description 2
- 240000001992 Angelica archangelica Species 0.000 abstract 1
- 240000008397 Ganoderma lucidum Species 0.000 abstract 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 240000002195 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 230000001502 supplementation Effects 0.000 abstract 1
- 239000002775 capsules Substances 0.000 description 15
- 239000000843 powders Substances 0.000 description 13
- 239000000284 extracts Substances 0.000 description 10
- 230000027939 micturition Effects 0.000 description 8
- 210000002307 Prostate Anatomy 0.000 description 4
- 210000002700 Urine Anatomy 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- AXONCVPTTFHNOI-UHFFFAOYSA-N Kairine Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 210000003708 Urethra Anatomy 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 229940079593 drugs Drugs 0.000 description 3
- 238000000034 methods Methods 0.000 description 3
- 239000007815 EtOH Substances 0.000 description 2
- 238000007560 sedimentation technique Methods 0.000 description 2
- 201000010874 syndrome Diseases 0.000 description 2
- 239000011901 water Substances 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 210000003414 Extremities Anatomy 0.000 description 1
- 208000006750 Hematuria Diseases 0.000 description 1
- 210000000088 Lip Anatomy 0.000 description 1
- 231100000614 Poisons Toxicity 0.000 description 1
- 210000003689 Pubic Bone Anatomy 0.000 description 1
- 210000003932 Urinary Bladder Anatomy 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000012141 concentrates Substances 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 230000003203 everyday Effects 0.000 description 1
- 239000010419 fine particles Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular materials Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000000203 mixtures Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001282 polysaccharides Polymers 0.000 description 1
- 239000002244 precipitates Substances 0.000 description 1
- 238000002360 preparation methods Methods 0.000 description 1
- 230000001047 pyretic Effects 0.000 description 1
- 239000002994 raw materials Substances 0.000 description 1
- 230000001954 sterilising Effects 0.000 description 1
- 239000003826 tablets Substances 0.000 description 1
- 239000003440 toxic substances Substances 0.000 description 1
Abstract
一种治疗慢性前列腺炎的中药，属疗泌尿系统疾病的中药领域；其目的是效果好，见效快；本发明采用板蓝根、当归、灵芝、地黄、三七、萹蓄、车前子等原料制成；它具有扶正培本，益气养血，活血化瘀，利尿通淋的作用，具有效果显著，药效确切，见效较快的优点。
Description
一种治疗慢性前列腺炎的中药
技术领域
[0001] 本发明属于治疗泌尿系统疾病的中药领域。 背景技术
[0002] 目前的用于治疗慢性前列腺炎的中药方面，存在两个方面的不足：一是效果不够 明显，二是见效比较迟缓，以致于大批慢性前列腺炎患者因长期得不到有效药物的治疗，经 常出现排尿异常——尿频、尿急、尿道灼热、尿不尽，以及尿道口“滴白”、前列腺区域疼痛， 迁延不愈，非常痛苦，日久常并发膀胱炎、血尿等症状。患者及其家属很不满意。
[0003] 针对以上提出的问题，本发明提供一种治疗慢性前列腺炎的中药，它能解决以往 此类中药效果不够明显，见效比较迟缓的问题，效果好，见效快，具有效果显著，药效确切， 见效较快的优点。
发明内容
[0004] 本发明是通过以下技术方案来实现的：
[0005] 1、一种治疗慢性前列腺炎的中药，采用中药原料制备，配方为（按重量比）：
[0006] 板蓝根6——18份 当归6——18份 灵芝6——18份
[0007] 地黄6——18份 三七3——9份 篇蓄5——15份
[0008] 车前子5——15份
[0009] 这种治疗慢性前列腺炎的中药是由下列方法制成的：
[0010] (1)按上述重量比，将灵芝用水提醇沉法提取灵芝多糖，工艺流程如下：将灵芝破 碎成颗粒状，过40目筛一用1 ： 20的热水（95°C )浸提一浸提液减压、浓缩一用3倍体积 的95%乙醇混合、静置10-12小时、离心一加75%的乙醇，沉淀多糖一烘干得灵芝多糖提取 物细粉；
[0011] (2)按上述重量比，将板蓝根、当归、地黄、篇蓄、车前子经常规水提取工艺提取，制 成提取物浸膏细粉；
[0012] (3)按上述重量比，将三七研成细粉，与上述（1)、(2)两种提取物细粉混合，搅拌 均勻，制成中药颗粒剂、胶囊剂、片剂。
[0013] 本发明根据民间传统配方，根据中医扶正培本、活血化瘀的理论，精心研制而成。 方中灵芝、地黄扶正培本，益气养血，增强免疫力，抗炎灭菌；当归、三七养血活血、化瘀止 痛；伍以板蓝根清热解毒，凉血、抗菌；篇蓄、车前子利尿通淋，善治膀胱热淋、淋漓涩痛。诸 药配伍，相得益彰，共奏扶正培本，益气养血，活血化瘀，利尿通淋之功，效果好，见效快，具 有效果显著，药效确切，见效较快的优点。
具体实施方式
[0014] 通过以下实施方式对本发明做具体说明：
[0015] 1、取以下配方（重量按克为单位）：[0016] 板蓝根70克 当归70克 灵芝70克
[0017] 地黄70克 三七30克 篇蓄50克
[0018] 车前子50克
[0019] 按规定重量，用水提醇沉法将灵芝进行提取；用常规水提取工艺将板蓝根、当归、 地黄、篇蓄、车前子提取，共制成提取物细粉76克，将三七研成细粉，与上述提取物细粉混 合，搅拌均勻，制成细小颗粒，装入0号胶囊，制成中药胶囊378粒，每粒胶囊内含中药细粉 及提取物0.观克。
[0020] 2、取以下配方（重量按克为单位）：
[0021] 板蓝根120克 当归120克 灵芝120克
[0022] 地黄120克 三七50克 篇蓄100克
[0023] 车前子100克
[0024] 按上述同样的方法，制成中药胶囊664粒，每粒胶囊内含中药细粉及提取物0. 28克。
[0025] 3、取以下配方（重量按克为单位）：
[0026] 板蓝根180克 当归180克 灵芝180克
[0027] 地黄180克 三七80克 篇蓄150克
[0028] 车前子150克
[0029] 按上述同样的方法，制成中药胶囊1014粒，每粒胶囊内含中药细粉及提取物0. 28克。
[0030] 4、取以下配方（按重量比）：
[0031] 板蓝根6份 当归6份 灵芝6份
[0032] 地黄6份 三七3份 篇蓄5份
[0033] 车前子5份
[0034] 按上述同样的方法，制成中药胶囊，每粒胶囊内含中药细粉及提取物0. 28克。
[0035] 5、取以下配方（按重量比）：
[0036] 板蓝根16份 当归16份 灵芝16份
[0037] 地黄16份 三七7份 篇蓄12份
[0038] 车前子12份
[0039] 按上述同样的方法，制成中药胶囊，每粒胶囊内含中药细粉及提取物0. 28克。
[0040] 临床资料：
[0041 ] 本发明以慢性前列腺炎为例，经6例临床观察。选择中医诊断慢性前列腺炎为标 准：男性肢软乏力，身体虚弱，排尿异常——尿频、尿急、尿道灼热、排尿无力、尿不尽；尿道 口“滴白”；前列腺区域——会阴部、肛门、耻骨上下区域疼痛。如上症状，即可确诊。在确诊 观察的对象中，全部为男性，无其它严重疾病，年龄为27岁-41岁，平均年龄36. 3岁。
[0042] 疗效判定：
[0043] 1、显效：体质增强，身上有劲；尿频、尿急、尿道灼热、尿不尽明显缓解；尿道口“滴 白”现象明显减少或消失；前列腺区域疼痛显著缓解。
[0044] 2、有效：体质增强，身上有劲；尿频、尿急、尿不尽有所缓解；前列腺区域疼痛有所 减轻。[0045] 3、无效：病症无变化。
[0046] 临床实验时，停服其它药物和保健营养品。服用本发明中药胶囊，观察3个月，为 一个疗程。服用方法：每日2次，每次4粒胶囊，每粒胶囊内含中药细粉及提取物0.¾克， 饭后温开水送服，1个月后症状即有缓解，服用3个月后，症状明显改善。临床实验的6人 中，显效3人，有效2人，无效1人，总有效率83. 3 %。
Claims (1)
1. 一种治疗慢性前列腺炎的中药，其特征是：它是以下列重量比的组分制成的：板蓝 根6——18份，当归6——18份，灵芝6——8份，地黄6——18份，三七3——9份，篇蓄 5——15份，车前子5——15份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105992043A CN102114122A (zh) | 2010-12-13 | 2010-12-13 | 一种治疗慢性前列腺炎的中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105992043A CN102114122A (zh) | 2010-12-13 | 2010-12-13 | 一种治疗慢性前列腺炎的中药 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102114122A true CN102114122A (zh) | 2011-07-06 |
Family
ID=44213122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105992043A CN102114122A (zh) | 2010-12-13 | 2010-12-13 | 一种治疗慢性前列腺炎的中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102114122A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102380037A (zh) * | 2011-09-16 | 2012-03-21 | 北京绿源求证科技发展有限责任公司 | 一种治疗慢性前列腺炎的中药 |
| CN102626458A (zh) * | 2012-02-28 | 2012-08-08 | 余谨文 | 泌尿消炎丸 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843787A (zh) * | 2009-10-28 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | 一种治疗前列腺增生的中药 |
| CN101843699A (zh) * | 2009-10-16 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | 一种治疗前列腺增生的中药 |
-
2010
- 2010-12-13 CN CN2010105992043A patent/CN102114122A/zh not_active Application Discontinuation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843699A (zh) * | 2009-10-16 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | 一种治疗前列腺增生的中药 |
| CN101843787A (zh) * | 2009-10-28 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | 一种治疗前列腺增生的中药 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102380037A (zh) * | 2011-09-16 | 2012-03-21 | 北京绿源求证科技发展有限责任公司 | 一种治疗慢性前列腺炎的中药 |
| CN102626458A (zh) * | 2012-02-28 | 2012-08-08 | 余谨文 | 泌尿消炎丸 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843773B (zh) | 一种治疗肝硬化的中药 | |
| CN101843787B (zh) | 一种治疗前列腺增生的中药 | |
| CN101843699B (zh) | 一种治疗前列腺增生的中药 | |
| CN104173969A (zh) | 一种治疗脾胃虚寒型慢性胃炎的中药制剂及其制备方法 | |
| CN101843694B (zh) | 一种治疗慢性肝炎的中药 | |
| CN102091188A (zh) | 一种治疗糖尿病性肾病的中药 | |
| CN103735843A (zh) | 一种治疗糖尿病的药物组合物 | |
| CN104056042A (zh) | 益肾补精丸及其生产方法 | |
| CN101530515B (zh) | 一种治疗糖尿病并发前列腺肿大的中药 | |
| CN102389473A (zh) | 一种治疗糖尿病性便秘的中药 | |
| CN101940674A (zh) | 一种治疗糖尿病周围神经病变的中药 | |
| CN101961386A (zh) | 一种治疗糖尿病性皮肤瘙痒的中药 | |
| CN102114074A (zh) | 一种治疗糖尿病性腹泻的中药 | |
| CN102138969A (zh) | 一种治疗糖尿病性腹泻的中药 | |
| CN102139049A (zh) | 一种治疗糖尿病性皮肤瘙痒的中药 | |
| CN102389530A (zh) | 一种治疗前列腺增生的中药 | |
| CN101427720A (zh) | 一种治疗糖尿病的高浓度溶泡茶及其制备方法 | |
| CN102048831A (zh) | 一种治疗肝硬化的中药 | |
| CN101879257A (zh) | 一种治疗肿瘤的中药 | |
| CN102389488A (zh) | 一种治疗糖尿病性视网膜病变的中药 | |
| CN102114172A (zh) | 一种治疗前列腺增生的中药 | |
| CN102172374A (zh) | 一种治疗前列腺增生的中药 | |
| CN101406594B (zh) | 一种治疗肺部肿瘤的中药 | |
| CN100509025C (zh) | 一种治疗糖尿病的药物 | |
| CN102327411A (zh) | 一种治疗糖尿病性胃麻痹的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110706 |